Studies by Kameda et al. and Glassman et al. included diabetic CKD patients and patients with pre-existing albuminuria, with both studies suggesting no changes in GFR, blood pressure, or albuminuria during follow-up of patients receiving anti-VEGF agents [54, 55]. Here, VEGFA is linked to chronic kidney disease.